DIBUCAINE CHOLINESTERASE - ANVISA Registration 10287411475
Access comprehensive regulatory information for DIBUCAINE CHOLINESTERASE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10287411475 and manufactured by ROCHE DIAGNOSTICS GMBH. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 2 companies making the same product including SENTINEL CH.SPA, SENTINEL CH. SPA, and 2 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
10287411475
25351642112201900
30280358000186
Company Information
Dates and Status
Feb 10, 2020
VIGENTE
09/18/2025 19:00:01
DIBUCAINE CHOLINESTERASE
Dibucaine CHE
SENTINEL CH.SPA
80146501806
Jul 23, 2012
DIBUCAINE CHOLINESTERASE
Alinity c Dibucaine CHE Reagent Kit
SENTINEL CH. SPA
80146502233
Nov 18, 2019
CHOLINESTERASE
CHED2-CHOLINESTERASE/DIBUCAINE GEN.2
ROCHE DIAGNOSTICS GMBH
10287410741
Jul 14, 2008
CHOLINESTERASE
COLINESTERASE DIALAB
DIALAB GMBH
10300390383
Dec 17, 2018
CHOLINESTERASE
Atellica CH Colinesterase (CHE)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
10345162109
Nov 13, 2017